365 related articles for article (PubMed ID: 10815799)
21. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells.
Choudhury GG; Mahimainathan L; Das F; Venkatesan B; Ghosh-Choudhury N
Cell Signal; 2006 Nov; 18(11):1854-64. PubMed ID: 16530387
[TBL] [Abstract][Full Text] [Related]
22. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.
Vignais ML; Sadowski HB; Watling D; Rogers NC; Gilman M
Mol Cell Biol; 1996 Apr; 16(4):1759-69. PubMed ID: 8657151
[TBL] [Abstract][Full Text] [Related]
23. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
Karni R; Jove R; Levitzki A
Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412
[TBL] [Abstract][Full Text] [Related]
25. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
Kochhar KS; Linnekin D; Iyer AP
Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
[TBL] [Abstract][Full Text] [Related]
26. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.
Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T
World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243
[TBL] [Abstract][Full Text] [Related]
27. p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells.
Aronica MG; Brizzi MF; Dentelli P; Rosso A; Yarden Y; Pegoraro L
Oncogene; 1996 Sep; 13(5):1017-26. PubMed ID: 8806691
[TBL] [Abstract][Full Text] [Related]
28. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
[TBL] [Abstract][Full Text] [Related]
29. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis.
Bowman T; Broome MA; Sinibaldi D; Wharton W; Pledger WJ; Sedivy JM; Irby R; Yeatman T; Courtneidge SA; Jove R
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7319-24. PubMed ID: 11404481
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta1-induced degradation of activated Src tyrosine kinase in rat fibroblasts.
Fukuda K; Kawata S; Tamura S; Matsuda Y; Inui Y; Igura T; Inoue S; Kudara T; Matsuzawa Y
Oncogene; 1998 Jul; 16(26):3349-56. PubMed ID: 9692542
[TBL] [Abstract][Full Text] [Related]
31. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
32. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
Keating MT; Escobedo JA; Fantl WJ; Williams LT
Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
[TBL] [Abstract][Full Text] [Related]
33. Multiple roles for Src in a PDGF-stimulated cell.
DeMali KA; Godwin SL; Soltoff SP; Kazlauskas A
Exp Cell Res; 1999 Nov; 253(1):271-9. PubMed ID: 10579928
[TBL] [Abstract][Full Text] [Related]
34. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
Benito M; Lorenzo M
Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
[TBL] [Abstract][Full Text] [Related]
35. Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation.
Marks DC; Csar XF; Wilson NJ; Novak U; Ward AC; Kanagasundarum V; Hoffmann BW; Hamilton JA
Mol Cell Biol Res Commun; 1999 May; 1(2):144-52. PubMed ID: 10356364
[TBL] [Abstract][Full Text] [Related]
36. A role for activated p21 ras in inhibition/regulation of platelet-derived growth factor (PDGF) type-beta receptor activation.
Zubiaur M; Forman LW; Stice LL; Faller DV
Oncogene; 1996 Mar; 12(6):1213-22. PubMed ID: 8649823
[TBL] [Abstract][Full Text] [Related]
37. Activation and association of Stat3 with Src in v-Src-transformed cell lines.
Cao X; Tay A; Guy GR; Tan YH
Mol Cell Biol; 1996 Apr; 16(4):1595-603. PubMed ID: 8657134
[TBL] [Abstract][Full Text] [Related]
38. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
Broome MA; Hunter T
Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
[TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha induction of STATs1, -3 DNA binding and growth arrest is independent of Lck and active mitogen-activated kinase in T cells.
Lund TC; Medveczky MM; Medveczky PG
Cell Immunol; 1999 Mar; 192(2):133-9. PubMed ID: 10087181
[TBL] [Abstract][Full Text] [Related]
40. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.
Ekman S; Thuresson ER; Heldin CH; Rönnstrand L
Oncogene; 1999 Apr; 18(15):2481-8. PubMed ID: 10229199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
